oandp-cro

Koln, Germany Founded: 1991 • Age: 35 yrs Acquired By Ergomed
Provider of clinical research and packaging services for pharmaceutical industry

About oandp-cro

oandp-cro is a company based in Koln (Germany) founded in 1991 was acquired by Ergomed in June 2016. oandp-cro operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.

Key Metrics

Investors in oandp-cro

oandp-cro has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ergomed.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Clinical CRO services for oncology and rare diseases are provided.
1997ergomedplc.comGuildford, United Kingdom
Premium access

Investor details for oandp-cro

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of oandp-cro

1 people are tracked at oandp-cro (1 in leadership).

NameRoleGroup
Wolfgang Oestreich
Managing DirectorLeadership
Premium access

Complete people profiles for oandp-cro

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of oandp-cro

2 dated milestones of oandp-cro across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded oandp-cro is founded.
  2. Exit Acquired by Ergomed.

Competitors of oandp-cro

oandp-cro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
wuxiapptec.com2000Shanghai, China$40M1,681
Provider of CRO and CDMO services
eurofins.com1987Luxembourg––
Laboratory testing and contract research services are provided globally.
ipsen.com1929––505
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
cheplapharm.com1998Mesekenhagen, Germany–840
Branded pharmaceutical products are developed, marketed, and distributed globally.
anipharmaceuticals.com1996Baudette, United States–600
Branded and generic prescription drugs are developed, manufactured, and marketed.
caidya.com2003Morrisville, United States$373M351
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
rednucleus.com2014Yardley, United States–176
Advisory, scientific, and medical communications provided for pharmaceutical industry.
aptar.com1992Crystal Lake, United States–232
Regulatory support, brand differentiation, and prototyping services are provided.
aliadatx.com2021Boston, United States$33M–
Provider of drug research & development services for multiple therapeutic areas
Premium access

Detailed competitors of oandp-cro

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to oandp-cro

10 companies that operate in the same segment as oandp-cro (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about oandp-cro

oandp-cro was founded in 1991.

oandp-cro is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.

Founded in 1991 in Cologne, Germany, oandp-cro operates within the pharmaceutical industry. Clinical research support and packaging solutions are provided to clients. Operations focus on ensuring compliance and efficiency in drug development processes. The company is led by Managing Director Wolfgang Oestreich. Services extend to various stages of pharmaceutical trials and product handling across Europe.

oandp-cro's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.

oandp-cro has 1 investor. Key investors include Ergomed.

Yes. oandp-cro was acquired by Ergomed in June 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available